Saudi FDA tells drug companies how to set up formal meetings
This article was originally published in SRA
Executive Summary
The Saudi Food and Drug Authority has issued guidance on the procedure that drug companies should follow to set up formal meetings with the agency when they are looking for advice on a specific matter1. Among other things, the guideline explains that a meeting request should include an explanation of how the proposed meeting would be of use to the company because not all meeting requests are accepted by the SFDA.